Literature DB >> 26234326

Perceived Barriers to Treatment for Alcohol Problems: A Latent Class Analysis.

Megan S Schuler1, Savitha Puttaiah1, Ramin Mojtabai1, Rosa M Crum1.   

Abstract

OBJECTIVE: Low rates of alcohol treatment seeking have been shown to be associated with perceived barriers to treatment, but heterogeneity in patterns of perceived barriers has not been explored. The study analyzed data from a population-based sample of adults with alcohol abuse and dependence in order to describe latent classes of individuals who reported one or more of 15 perceived barriers to seeking alcohol treatment and to identify characteristics associated with class membership.
METHODS: Data were from the National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002). Analyses were restricted to treatment-naive adults with alcohol abuse or dependence who reported a perceived treatment need (N=1,053). Latent class analysis was performed to identify subgroups with respect to barriers to treatment. Latent class regression identified variables associated with each subgroup.
RESULTS: Two subgroups emerged: the low-barriers class (87%), characterized primarily by attitudinal barriers, and the high-barriers class (13%), characterized by significant attitudinal, financial, stigma, and readiness-for-change barriers. In both classes, the most frequently endorsed barrier was the attitudinal belief that "I should be strong enough" to handle the problem without treatment. Univariate analyses showed strong associations between membership in the high-barriers class and comorbid psychiatric disorders, alcohol dependence (compared with abuse), and a family history of alcohol problems. Multivariate analyses found significant associations with a lifetime anxiety disorder and with education level.
CONCLUSIONS: Attitudinal barriers were most prevalent. Findings revealed a notable subgroup with multiple barriers, including financial and stigma-related barriers. This subgroup may require additional resources and support to enter treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26234326      PMCID: PMC4630073          DOI: 10.1176/appi.ps.201400160

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  39 in total

Review 1.  Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders.

Authors:  William R Miller; Paula L Wilbourne
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

2.  Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study.

Authors:  Ramin Mojtabai; Rosa M Crum
Journal:  Drug Alcohol Depend       Date:  2012-07-04       Impact factor: 4.492

3.  Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders.

Authors:  Ramin Mojtabai; Lian-Yu Chen; Christopher N Kaufmann; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2013-08-29

4.  Predictors of help seeking among a longitudinal sample of the general population, 1984-1992.

Authors:  L A Kaskutas; C Weisner; R Caetano
Journal:  J Stud Alcohol       Date:  1997-03

5.  Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders.

Authors:  Christopher N Kaufmann; Lian-Yu Chen; Rosa M Crum; Ramin Mojtabai
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-07-31       Impact factor: 4.328

6.  Estimating the effect of help-seeking on achieving recovery from alcohol dependence.

Authors:  Deborah A Dawson; Bridget F Grant; Frederick S Stinson; Patricia S Chou
Journal:  Addiction       Date:  2006-06       Impact factor: 6.526

7.  Factors affecting the initiation of substance abuse treatment in managed care.

Authors:  C Weisner; J Mertens; T Tam; C Moore
Journal:  Addiction       Date:  2001-05       Impact factor: 6.526

8.  Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.

Authors:  Ramin Mojtabai; Mark Olfson; David Mechanic
Journal:  Arch Gen Psychiatry       Date:  2002-01

9.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

10.  Latent class analysis of early developmental trajectory in baby siblings of children with autism.

Authors:  Rebecca J Landa; Alden L Gross; Elizabeth A Stuart; Margaret Bauman
Journal:  J Child Psychol Psychiatry       Date:  2012-05-10       Impact factor: 8.982

View more
  23 in total

1.  Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.

Authors:  Meredith G Harris; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Ali Al-Hamzawi; Jordi Alonso; Ronny Bruffaerts; José Miguel Caldas de Almeida; Alfredo H Cia; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Hristo Hinkov; Elie G Karam; Georges Karam; Sing Lee; Jean-Pierre Lépine; Daphna Levinson; Victor Makanjuola; John McGrath; Zeina Mneimneh; Fernando Navarro-Mateu; Marina Piazza; José Posada-Villa; Charlene Rapsey; Hisateru Tachimori; Margreet Ten Have; Yolanda Torres; Maria Carmen Viana; Somnath Chatterji; Alan M Zaslavsky; Ronald C Kessler; Louisa Degenhardt
Journal:  Addiction       Date:  2019-06-02       Impact factor: 6.526

2.  Heterogeneity in the Co-occurrence of Substance Use and Posttraumatic Stress Disorder: A Latent Class Analysis Approach.

Authors:  Ateka A Contractor; Nicole H Weiss; Katherine L Dixon-Gordon; Heidemarie Blumenthal
Journal:  J Dual Diagn       Date:  2019-03-06

3.  Rates of past-year alcohol treatment across two time metrics and differences by alcohol use disorder severity and mental health comorbidities.

Authors:  Rebecca Evans-Polce; Megan S Schuler
Journal:  Drug Alcohol Depend       Date:  2016-07-20       Impact factor: 4.492

4.  Public attitudes towards psychiatry and psychiatric treatment at the beginning of the 21st century: a systematic review and meta-analysis of population surveys.

Authors:  Matthias C Angermeyer; Sandra van der Auwera; Mauro G Carta; Georg Schomerus
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

5.  Influence of gender and race/ethnicity on perceived barriers to help-seeking for alcohol or drug problems.

Authors:  Angie Denisse Otiniano Verissimo; Christine E Grella
Journal:  J Subst Abuse Treat       Date:  2017-01-25

6.  Identification of Distinct Latent Classes Related to Sleep, PTSD, Depression, and Anxiety in Individuals Diagnosed With Severe Alcohol Use Disorder.

Authors:  Gwenyth R Wallen; Jumin Park; Michael Krumlauf; Alyssa T Brooks
Journal:  Behav Sleep Med       Date:  2018-01-29       Impact factor: 2.964

7.  How should prevalence of alcohol use disorders be assessed globally?

Authors:  Jürgen Rehm
Journal:  Int J Methods Psychiatr Res       Date:  2016-05-01       Impact factor: 4.035

8.  Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder.

Authors:  Carolina Barbosa; William N Dowd; Arnie P Aldridge; Christine Timko; Gary A Zarkin
Journal:  Med Decis Making       Date:  2019-10-03       Impact factor: 2.583

Review 9.  State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.

Authors:  Lara A Ray; Spencer Bujarski; Erica Grodin; Emily Hartwell; ReJoyce Green; Alexandra Venegas; Aaron C Lim; Artha Gillis; Karen Miotto
Journal:  Am J Drug Alcohol Abuse       Date:  2018-10-29       Impact factor: 3.829

10.  Barriers to retention in substance use treatment: Validation of a new, theory-based scale.

Authors:  Sarah E Zemore; Orrin D Ware; Paul A Gilbert; Miguel Pinedo
Journal:  J Subst Abuse Treat       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.